Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long MRNA ETF

142.97
+12.519.59%
Pre-market: 139.90-3.0700-2.15%04:17 EDT
Volume:258.20K
Turnover:35.15M
Market Cap:75.77M
PE:- -
High:144.32
Open:124.62
Low:123.44
Close:130.46
52wk High:167.89
52wk Low:14.95
Shares:530.00K
Float Shares:530.00K
Volume Ratio:1.13
T/O Rate:48.72%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

It's Inflation Day and the Stock Market is on Edge

Dow Jones
·
Sep 30

Moderna Stock Has Run Too Far, Too Fast. Why Citi Just Downgraded it to Sell

Dow Jones
·
Sep 30

Moderna Slips After Citi Downgrades to 'sell'

Reuters
·
Sep 30

Moderna appoints Juan Andres as COO

TIPRANKS
·
Sep 30

Citi Downgrades Moderna Stock after 222% Rally, Calls Oncology Expectations “Unrealistic”

TIPRANKS
·
Sep 30

Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains

Dow Jones
·
Sep 30

Moderna Adds Chief Operating Officer Role as Company Expands into Oncology

THOMSON REUTERS
·
Sep 30

Moderna: Juan Andres to Return to Moderna as Chief Operating Officer - Website

THOMSON REUTERS
·
Sep 30

Moderna Appoints Juan Andres as Chief Operating Officer

Reuters
·
Sep 30

Moderna Price Target Raised to $80.00/Share from $60.00 by Citigroup

Dow Jones
·
Sep 30

Moderna : Citigroup Cuts to Sell from Neutral; Raises Target Price to $80 from $60

THOMSON REUTERS
·
Sep 30

Moderna sinks 4% to $195.42 after Citi downgrades to Sell

TIPRANKS
·
Sep 30

US Research Roundup-Alnylam Pharmaceuticals, Carvana, MongoDB

Reuters
·
Sep 30

Hong Kong Stocks Midday Review: Hang Seng Index Slips 0.04% in Morning Session, CRO-Related Shares Lead Gains

Stock News
·
Sep 30

Moderna Inc. Stock Climbs 3.1%, Outperforms Peers

Dow Jones
·
Sep 30

$20 Billion In Deals And Counting: Lilly's CEO Targets The "White Space" Of Science For Larger M&A

Options & Short Sell
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Inventiva (IVA) and Moderna (MRNA)

TIPRANKS
·
Sep 29

Judge Rejects Pfizer, BioNTech, and Moderna Bid to Dismiss Monsanto mRNA Patent Lawsuit

Stock News
·
Sep 29

AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours

Options & Short Sell
·
Sep 29

Teva announces FDA approval of Degevma as a biosimilar to Xgeva

TIPRANKS
·
Sep 29